Biogen Inc. (VIE:BIIB)
Austria · Delayed Price · Currency is EUR 162.75
+2.10 (1.31%)
At close: Mar 5, 2026
Biogen Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,293 | 1,632 | 1,162 | 2,962 | 1,728 |
Depreciation & Amortization | 779.9 | 673.2 | 494.8 | 518.4 | 487.7 |
Stock-Based Compensation | 290.8 | 291.2 | 264.2 | 254.1 | 238.6 |
Other Adjustments | 898.6 | 434.1 | 275.4 | -1,460 | 1,332 |
Change in Receivables | 42.1 | 194.2 | 56.7 | -222.4 | 326 |
Changes in Inventories | -64.7 | -273.8 | -130.9 | -320.2 | -462.4 |
Changes in Accrued Expenses | 171.1 | 24.6 | -201.6 | -113.4 | -95.4 |
Changes in Income Taxes Payable | -958.1 | 78.5 | -299 | -142.3 | 230.8 |
Changes in Other Operating Activities | -248 | -178.7 | -73.9 | -92 | -144.5 |
Operating Cash Flow | 2,205 | 2,876 | 1,547 | 1,384 | 3,640 |
Operating Cash Flow Growth | -23.33% | 85.85% | 11.77% | -61.97% | -13.95% |
Capital Expenditures | -153.8 | -153.7 | -277 | -240.3 | -258.1 |
Sale of Property, Plant & Equipment | - | - | - | 582.6 | 93.5 |
Purchases of Intangible Assets | -81.6 | -206.1 | -34.4 | -2.9 | -36.8 |
Proceeds from Sale of Intangible Assets | - | 88.6 | - | - | - |
Purchases of Investments | -1,258 | - | -5,141 | -3,449 | -3,809 |
Proceeds from Sale of Investments | 79.7 | 551.5 | 8,289 | 4,661 | 3,405 |
Payments for Business Acquisitions | - | -1,075 | -6,926 | - | - |
Proceeds from Business Divestments | - | 406.8 | 788.1 | 990.3 | 28.1 |
Other Investing Activities | -7.1 | 83.9 | -11.3 | 24.4 | -5.1 |
Investing Cash Flow | -1,371 | -799.2 | -4,101 | 1,577 | -563.7 |
Long-Term Debt Issued | 1,733 | - | 997.2 | - | - |
Long-Term Debt Repaid | -1,750 | -650 | -809.9 | -1,002 | -170 |
Net Long-Term Debt Issued (Repaid) | -16.9 | -650 | 187.3 | -1,002 | -170 |
Repurchase of Common Stock | - | - | - | -750 | -1,800 |
Net Common Stock Issued (Repurchased) | - | - | - | -750 | -1,800 |
Other Financing Activities | -285 | -33.5 | -38 | 4.9 | -116.2 |
Financing Cash Flow | -301.9 | -683.5 | 149.3 | -1,747 | -2,086 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 101.9 | -67.7 | 35.1 | -55.7 | -59.8 |
Net Cash Flow | 531.6 | 1,393 | -2,405 | 1,214 | 990 |
Free Cash Flow | 2,051 | 2,722 | 1,270 | 1,144 | 3,382 |
Free Cash Flow Growth | -24.65% | 114.28% | 11.03% | -66.17% | -11.12% |
FCF Margin | 20.73% | 28.13% | 12.91% | 11.25% | 30.79% |
Free Cash Flow Per Share | 13.94 | 18.66 | 8.72 | 7.84 | 22.61 |
Levered Free Cash Flow | 802.4 | 1,152 | 860.8 | 1,570 | 1,316 |
Unlevered Free Cash Flow | 1,073 | 2,097 | 956.48 | 2,480 | 2,513 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.